Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis.
Michael I GurinSebastian E BeyerMitchell WeinbergSahil A ParikhEhrin J ArmstrongMazen S AlbaghdadiHerbert D AronowBrett J CarrollRobert YehEric A SecemskyPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
DCBs are less often used compared to uncoated balloons during inpatient femoropopliteal procedures. While DCB utilization is associated with more severe comorbidities and advanced peripheral artery disease, readmission rates are decreased through the first 6 months.